Hepatic lipase activity during oral and parenteral 17β-estradiol replacement therapy: high-density lipoprotein increase may not be antiatherogenic
- 1 June 1991
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 55 (6) , 1112-1117
- https://doi.org/10.1016/s0015-0282(16)54361-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal womenThe Lancet, 1990
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- Deficiencies of plasma lipolytic activitiesAmerican Heart Journal, 1987
- Regulation of hepatic lipase and serum lipoproteins by sex steroidsAmerican Heart Journal, 1987
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol.Proceedings of the National Academy of Sciences, 1986
- Variation of postheparin plasma hepatic lipase by menstrual cycleMetabolism, 1986
- Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Hydrolysis of human plasma high density lipoprotein2-phospholipids and triglycerides by hepatic lipaseBiochemical and Biophysical Research Communications, 1981